| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PATH.1711770307 |
| P8608 | Fatcat ID | release_ri53fd6545cm3ltxxqikjmozvi |
| P698 | PubMed publication ID | 8551387 |
| P50 | author | Giuseppe Giaccone | Q37829946 |
| Takashi Takahashi | Q56945207 | ||
| P2093 | author name string | Izquierdo MA | |
| Scheper RJ | |||
| Ueda R | |||
| Rubio G | |||
| Van der Valk P | |||
| Van Ark-Otte J | |||
| Germa-Lluch JR | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 253-258 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Differential expression of the c-kit proto-oncogene in germ cell tumours | |
| P478 | volume | 177 |
| Q44068928 | Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer |
| Q80551972 | Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors |
| Q44490297 | Alterations of the c-kit gene in testicular germ cell tumors |
| Q44853377 | C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections |
| Q30698402 | CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma |
| Q35258032 | CK19 is a sensitive marker for yolk sac tumours of the testis |
| Q34388573 | Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications |
| Q33568982 | Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors. |
| Q47581497 | D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30. |
| Q80873815 | Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clones |
| Q34502475 | Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects |
| Q48001266 | Differential expression of SOX2 and SOX17 in testicular germ cell tumors |
| Q37044517 | Differential expression of c-kit and CD43 in histological subtypes of adenoid cystic carcinoma of salivary gland |
| Q40891073 | Differential expression of p53, c-kit, and CD34 in prepubertal and postpubertal testicular germ cell tumors |
| Q36230915 | Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters |
| Q38602699 | Emerging Therapeutic Targets for Male Germ Cell Tumors |
| Q26991452 | Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis |
| Q46628435 | Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications |
| Q43037368 | Expression of EGFR, HER-2/neu and KIT in germ cell tumours. |
| Q43938162 | Expression of the PDGF alpha-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms |
| Q41885351 | Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate |
| Q37125454 | Genes, chromosomes and the development of testicular germ cell tumors of adolescents and adults |
| Q35598887 | Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors |
| Q42099799 | Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours |
| Q48262511 | IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance |
| Q51946531 | Intratubular germ cell neoplasia of unclassified type occupying the whole testis accompanied by a small mature teratoma and metastatic choriocarcinoma and Sertoli cell‐only tubules in the other testis |
| Q35083255 | KIT mutations are common in testicular seminomas |
| Q36739091 | Morphological approach to tumours of the testis and paratestis |
| Q36121338 | Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma |
| Q47614258 | Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders |
| Q35996493 | Pathology of germ cell tumors of the testis |
| Q46089831 | Receptor tyrosine kinases in sinonasal undifferentiated carcinomas--evaluation for EGFR, c-KIT, and HER2/neu expression |
| Q38436467 | Risk of germ cell malignancy in children with XY intersex versus isolated cryptorchidism by immunohistochemistry. |
| Q53192088 | Salivary gland cancers: biology and molecular targets for therapy. |
| Q37308461 | Stage-specific localization and expression of c-kit in the adult human testis. |
| Q57837665 | Targeted therapies for patients with germ cell tumors |
| Q37853838 | Testicular germ cell tumours: predisposition genes and the male germ cell niche. |
| Q38264052 | The SCF/c-KIT system in the male: Survival strategies in fertility and cancer |
| Q35129514 | The emerging phenotype of the testicular carcinoma in situ germ cell |
| Q38451399 | The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus |
| Q39401758 | The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer |
| Q35129484 | The testicular germ cell tumour genome |
| Q24306212 | Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors |
| Q87705342 | [Testicular seminomas. The classical and the less classical ones] |
| Q38451233 | c-Kit is not expressed in malignant mesothelioma |
| Q45095957 | c-kit gene mutations in intracranial germinomas |
Search more.